B-type natriuretic peptide versus amino terminal pro-B type natriuretic peptide: Selecting the optimal heart failure marker in patients with impaired kidney function

BMC Nephrology

Volumn 14, Issue 1, 2013, Pages

  Jafri, Lena ^a   Kashif, Waqar ^b   Tai, Javed ^b   Siddiqui, Imran ^a   Azam, Iqbal ^a   Shahzad, Hira ^c   Ghani, Farooq ^a  

^a AGA KHAN UNIVERSITY   (Pakistan)

^b AGA KHAN UNIVERSITY HOSPITAL   (Pakistan)

^c AGA KHAN UNIVERSITY MEDICAL COLLEGE   (Pakistan)

Author keywords

B Type natriuretic peptide; Heart failure; Kidney; NT proBNP

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BRAIN NATRIURETIC PEPTIDE; CREATININE;

ADULT; ARTICLE; BLOOD SAMPLING; CARDIOLOGIST; CHRONIC KIDNEY DISEASE; CLINICAL ASSESSMENT; CREATININE BLOOD LEVEL; CROSS-SECTIONAL STUDY; DISEASE MARKER; FEMALE; GLOMERULUS FILTRATION RATE; HEART FAILURE; HUMAN; KIDNEY DYSFUNCTION; MAJOR CLINICAL STUDY; MALE;

ADULT; AGED; BIOLOGICAL MARKERS; CROSS-SECTIONAL STUDIES; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; RENAL INSUFFICIENCY, CHRONIC;

EID: 84878376501     PISSN: None     EISSN: 14712369     Source Type: Journal    
DOI: 10.1186/1471-2369-14-117     Document Type: Article

References (46)

1. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: third national health and nutrition examination survey. Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS, Am J Kidney Dis 2003 41 1 1 12 12500213 (Pubitemid 36043346)
2. Prevalence of kidney damage in Australian adults: The AusDiab kidney study. Chadban SJ, Briganti EM, Kerr PG, Dunstan DW, Welborn TA, Zimmet PZ, Atkins RC, J Am Soc Nephrol 2003 14 131 S138 10.1097/01.ASN.0000070152.11927.4A 12819318
3. Application of GFR-estimating equations in Chinese patients with chronic kidney disease. Zuo L, Ma YC, Zhou YH, Wang M, Xu GB, Wang HY, Am J Kidney Dis 2005 45 3 463 472 10.1053/j.ajkd.2004.11.012 15754268 (Pubitemid 40341325)
4. Prevalence of chronic kidney disease in the United States. Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, Van Lente F, Levey AS, JAMA 2007 298 2038 2047 10.1001/jama.298.17.2038 17986697 (Pubitemid 350074801)
5. Serum creatinine as marker of kidney function in South Asians: a study of reduced GFR in adults in Pakistan. Jafar TH, Schmid CH, Levey AS, J Am Soc Nephrol 2005 16 5 1413 1419 10.1681/ASN.2004121100 15800118 (Pubitemid 41716525)
6. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. King H, Aubert RE, Herman WH, Diabetes Care 1998 21 9 1414 1431 10.2337/diacare.21.9.1414 9727886 (Pubitemid 28405191)
7. Hypertension and stroke in Asia: prevalence, control and strategies in developing countries for prevention. Singh RB, Suh IL, Singh VP, Chaithiraphan S, Laothavorn P, Sy RG, Babilonia NA, Rahman AR, Sheikh S, Tomlinson B, Sarraf-Zadigan N, J Hum Hypertens 2000 14 749 763 10.1038/sj.jhh.1001057 11095165
8. The frequency of known diabetes, hypertension and ischaemic heart disease in affluent and poor urban populations of Karachi, Pakistan. Hameed K, Kadir M, Gibson T, Sultana S, Fatima Z, Syed A, Diabet Med 1995 12 6 500 503 10.1111/j.1464-5491.1995.tb00531.x 7648823
9. Congestive heart failure in chronic kidney disease: disease-specific mechanisms of systolic and diastolic heart failure and management. Curtis BM, Parfrey PS, Cardiol Clin 2005 23 3 275 284 10.1016/j.ccl.2005.04.002 16084277 (Pubitemid 41097351)
10. Plasma amino-terminal pro-brain natriuretic peptide and accuracy of heart-failure diagnosis in primary care: a randomized, controlled trial. Wright SP, Doughty RN, Pearl A, Gamble GD, Whalley GA, Walsh HJ, Gordon G, Bagg W, Oxenham H, Yandle T, Richards M, Sharpe N, J Am Coll Cardiol 2003 42 1793 1800 10.1016/j.jacc.2003.05.011 14642690 (Pubitemid 37433660)
11. Use of plasma brain natriuretic peptide concentration to aid in the diagnosis of heart failure. Shapiro BP, Chen HH, Burnett JC Jr, Redfield MM, Mayo Clin Proc 2003 78 4 481 486 10.4065/78.4.481 12683700 (Pubitemid 36373949)
12. B-type natriuretic peptide and renal function in the diagnosis of heart failure: an analysis from the Breathing Not Properly Multinational Study. McCullough PA, Duc P, Omland T, McCord J, Nowak RM, Hollander JE, Herrmann HC, Steg PG, Westheim A, Knudsen CW, Storrow AB, Abraham WT, Lamba S, Wu AHB, Perez A, Clopton P, Krishnaswamy P, Kazanegra R, Maisel AS, Am J Kidney Dis 2003 41 3 571 579 10.1053/ajkd.2003.50118 12612980 (Pubitemid 36278374)
13. Natriuretic peptides and heart failure in the patient with chronic kidney disease: a review of current evidence. Dhar S, Pressman GS, Subramanian S, Kaul S, Gollamudi S, Bloom EJ, Figueredo VM, Postgrad Med J 2009 85 299 302 10.1136/pgmj.2008.073734 19528304
14. Thirty years of the heart as an endocrine organ: physiological role and clinical utility of cardiac natriuretic hormones. Clerico A, Giannoni A, Vittorini S, Passino C, Am J Physiol Heart Circ Physiol 301 1 12 H20
15. Natriuretic peptides. Daniels LB, Maisel AS, J Am Coll Cardiol 2007 50 25 2357 2368 10.1016/j.jacc.2007.09.021 18154959 (Pubitemid 50011582)
16. Secretion of glycosylated pro-B-type natriuretic peptide from normal cardiomyocytes. Tonne JM, Campbell JM, Cataliotti A, Ohmine S, Thatava T, Sakuma T, Macheret F, Huntley BK, Burnett JC Jr, Ikeda Y, Clin Chem 57 864 873
17. Rapid ventricular induction of brain natriuretic peptide gene expression in experimental acute myocardial infarction. Hama N, Itoh H, Shirakami G, Nakagawa O, Suga S, Ogawa Y, Masuda I, Nakanishi K, Yoshimasa T, Hashimoto Y, Circulation 1995 92 1558 1564 10.1161/01.CIR.92.6.1558 7664440
18. A 94-kDa protein, identified as neutral endopeptidase-24.11, can inactivate atrial natriuretic peptide in the vascular endothelium. Soleilhac JM, Lucas E, Beaumont A, Turcaud S, Michel JB, Ficheux D, Fournie-Zaluski MC, Roques BP, Mol Pharmacol 1992 41 609 614 1533267 (Pubitemid 23021445)
19. Brain and other natriuretic peptides: molecular aspects. Vanderheyden M, Bartunek J, Goethals M, Eur J Heart Fail 2004 6 3 261 268 10.1016/j.ejheart. 2004.01.004 14987574 (Pubitemid 38253044)
20. The natriuretic peptides in heart failure: diagnostic and therapeutic potentials. Chen HH, Burnett JC Jr, Proc Assoc Am Physicians 1999 111 5 406 416 10519161 (Pubitemid 29446883)
21. B-type natriuretic peptides: a diagnostic breakthrough for clinicians. McCullough PA, Omland T, Maisel AS, Rev Cardiovasc Med 2003 4 2 72 80 12776016 (Pubitemid 36701300)
22. Natriuretic peptides. Levin ER, Gardner DG, Samson WK, N Engl J Med 1998 339 5 321 328 10.1056/NEJM199807303390507 9682046 (Pubitemid 28366422)
23. Prediction of creatinine clearance from serum creatinine. Cockcroft DW, Gault MH, Nephron 1976 16 1 31 41 10.1159/000180580 1244564
24. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002 39 2 Suppl 1 1 S266 11904577
25. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, Poole-Wilson PA, Stromberg A, van Veldhuisen DJ, Atar D, Hoes AW, Keren A, Mebazaa A, Nieminen M, Priori SG, Swedberg K, Eur Heart J 2008 29 19 2388 2442 18799522
26. Increase in circulating levels of cardiac natriuretic peptides after hormone replacement therapy in postmenopausal women. Maffei S, Del Ry S, Prontera C, Clerico A, Clin Sci (Lond) 2001 101 5 447 453 10.1042/CS20010039 (Pubitemid 33032988)
27. Effects of estrogen replacement therapy on natriuretic peptides and blood pressure. Karjalainen AH, Ruskoaho H, Vuolteenaho O, Heikkinen JE, Backstrom AC, Savolainen MJ, Kesaniemi YA, Maturitas 2004 47 201 208 10.1016/S0378- 5122(03)00279-2 15036490 (Pubitemid 38270398)
28. NT-ProBNP in outpatients after myocardial infarction: interaction between symptoms and left ventricular function and optimized cut-points. Luchner A, Hengstenberg C, Lowel H, Buchner S, Schunkert H, Riegger GA, Holmer S, J Card Fail 2005 11 21 27 10.1016/j.cardfail.2005.04.018 15948096
29. Impact of renal disease on natriuretic peptide testing for diagnosing decompensated heart failure and predicting mortality. deFilippi CR, Seliger SL, Maynard S, Christenson RH, Clin Chem 2007 53 8 1511 1519 10.1373/clinchem.2006. 084533 17586595 (Pubitemid 47206349)
30. Renal function, congestive heart failure, and amino-terminal pro-brain natriuretic peptide measurement: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) Study. Anwaruddin S, Lloyd-Jones DM, Baggish A, Chen A, Krauser D, Tung R, Chae C, Januzzi JL Jr, J Am Coll Cardiol 2006 47 91 97 10.1016/j.jacc.2005.08.051 16386670 (Pubitemid 43005170)
31. Effect of compensated renal dysfunction on approved heart failure markers: direct comparison of brain natriuretic peptide (BNP) and N-terminal pro-BNP. Luchner A, Hengstenberg C, Lowel H, Riegger GA, Schunkert H, Holmer S, Hypertension 2005 46 1 118 123 10.1161/01.HYP.0000170140.36633.8f 15939804 (Pubitemid 40946501)
32. Natriuretic peptides in the diagnosis and management of heart failure. Felker GM, Petersen JW, Mark DB, CMAJ 2006 175 6 611 617 16966666 (Pubitemid 44439724)
33. National Clinical Guideline Centre (UK), Chronic Heart Failure: National Clinical Guideline for Diagnosis and Management in Primary and Secondary Care: Partial Update [Internet] London: Royal College of Physicians (UK) 2010 (NICE Clinical Guidelines, No. 108.) Available from: http://www.ncbi.nlm.nih.gov/ books/NBK65340/
34. 2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. Jessup M, Abraham WT, Casey DE, Feldman AM, Francis GS, Ganiats TG, Konstam MA, Mancini DM, Rahko PS, Silver MA, Stevenson LW, Yancy CW, Circulation 2009 119 1977 2016 19324967
35. Diagnostic and therapeutic utility of B-type natriuretic peptide in patients with renal insufficiency and decompensated heart failure. McCullough PA, Kuncheria J, Mathur VS, Rev Cardiovasc Med. 2003 4 Suppl 7 3 S12 14668704
36. Relationship between serum brain natriuretic peptide and heart function in patients with chronic kidney disease. Yang JW, Kim MS, Kim JS, Yoo JM, Han ST, Kim BR, Kim YD, Choi SO, Han BG, Korean J Intern Med 2008 23 191 200 10.3904/kjim.2008.23.4.191 19119256
37. B-type natriuretic peptide and clinical judgment in emergency diagnosis of heart failure: analysis from Breathing Not Properly (BNP) Multinational Study. McCullough PA, Nowak RM, McCord J, Hollander JE, Herrmann HC, Steg PG, Duc P, Westheim A, Omland T, Knudsen CW, Circulation 2002 106 416 422 10.1161/01.CIR.0000025242.79963.4C 12135939 (Pubitemid 34803684)
38. N-terminal proB-type natriuretic peptide levels aid the diagnosis of left ventricular dysfunction in patients with severe acute exacerbations of chronic obstructive pulmonary disease and renal dysfunction. Ouanes I, Jalloul F, Ayed S, Dachraoui F, Ouanes-Besbes L, Fekih Hassen M, Elatrous S, Abroug F, Respirology 17 660 666
39. Association of plasma amino-terminal pro-A-, B- and C-type natriuretic peptide levels with NYHA grade and echocardiographic derived parameters of cardiac function in heart failure patients. Zhao XY, Yang YJ, Zhang J, Kang LM, Wei BQ, Gao XJ, Lu R, Zhang CL, Zhonghua Xin Xue Guan Bing Za Zhi 2009 37 486 490 19927626
40. Plasma brain natriuretic peptide levels increase in proportion to the extent of right ventricular dysfunction in pulmonary hypertension. Nagaya N, Nishikimi T, Okano Y, Uematsu M, Satoh T, Kyotani S, Kuribayashi S, Hamada S, Kakishita M, Nakanishi N, Takamiya M, Kunieda T, Matsuo H, Kangawa K, J Am Coll Cardiol 1998 31 202 208 9426041 (Pubitemid 28064743)
41. Association of N-terminal pro-B-type natriuretic peptide with left ventricular structure and function in chronic kidney disease (from the Chronic Renal Insufficiency Cohort [CRIC]). Mishra RK, Li Y, Ricardo AC, Yang W, Keane M, Cuevas M, Christenson R, deFilippi C, Chen J, He J, Kallem RR, Raj DS, Schelling JR, Wright J, Go AS, Shlipak MG, Am J Cardiol 111 432 438
42. Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction. Tsutamoto T, Wada A, Maeda K, Hisanaga T, Maeda Y, Fukai D, Ohnishi M, Sugimoto Y, Kinoshita M, Circulation 1997 96 509 516 10.1161/01.CIR.96.2.509 9244219 (Pubitemid 27329427)
43. The paradox of increased natriuretic hormones in congestive heart failure patients: does the endocrine heart also fail in heart failure? Goetze JP, Kastrup J, Rehfeld JF, Eur Heart J 2003 24 16 1471 1472 10.1016/S0195-668X(03) 00283-5 12919769 (Pubitemid 37010575)
44. Biochemistry of pro-B-type natriuretic peptide-derived peptides: the endocrine heart revisited. Goetze JP, Clin Chem 2004 50 9 1503 1510 10.1373/clinchem.2004.034272 15265821 (Pubitemid 39121217)
45. Heart failure: a state of brain natriuretic peptide deficiency or resistance or both! Chen HH, J Am Coll Cardiol. 2007 49 10 1089 1091 10.1016/j.jacc.2006.12.013 17349889 (Pubitemid 46389361)
46. State of the art of BNP and NT-proBNP immunoassays: the CardioOrmoCheck study. Clerico A, Zaninotto M, Prontera C, Giovannini S, Ndreu R, Franzini M, Zucchelli GC, Plebani M, Clin Chim Acta 414 112 119